Valsts: Īrija
Valoda: angļu
Klimata pārmaiņas: HPRA (Health Products Regulatory Authority)
Riboflavin; Biotin; Thiamine hydrochloride; Acetomenaphthone; Nicotinamide; Pyridoxine hydrochloride; Ascorbic acid; Folic acid; Tocopherol acetate; Inositol; Calcium pantothenate
Essential Pharmaceuticals Limited
A11EX
Riboflavin; Biotin; Thiamine hydrochloride; Acetomenaphthone; Nicotinamide; Pyridoxine hydrochloride; Ascorbic acid; Folic acid; Tocopherol acetate; Inositol; Calcium pantothenate
0 percent volume/volume
Tablet
Vitamin B-complex, other combinations
Not marketed
2012-05-25
Package leaflet: Information for the user Ketovite Tablets Multivitamin preparation Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist have told you. • Keep this leaflet. You may need to read it again. • Ask your pharmacist if you need more information or advice. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. • You must talk to a doctor if you do not feel better or if you feel worse. What is in this leaflet 1. What Ketovite Tablets are and what they are used for 2. What you need to know before you take Ketovite Tablets 3. How to take Ketovite Tablets 4. Possible side effects 5. How to store Ketovite Tablets 6. Contents of the pack and other information 1. What Ketovite Tablets are and what they are used for Ketovite Tablets are a therapeutic vitamin supplement for the prevention of vitamin deficiency. It is used in conditions such as: • galactosaemia (a disorder of milk sugar digestion) • disaccharide intolerance (a reaction to sugars such as sucrose, lactose and maltose) • phenylketonuria (an inability to digest one of the essential amino acids) • in other disorders of starch, sugar or amino acid metabolism • in patients who are on restricted, specialised or synthetic diets. Ketovite Tablets are a multivitamin preparation, intended for use at the same time as Ketovite Liquid. 2. What you need to know before you take Ketovite Tablets Do not take Ketovite Tablets: • if you are allergic to any of the ingredients of the tablets (listed in section 6). Warnings and precautions • Ketovite Tablets contains 0.17 mg biotin per tablet. If you are about to undergo laboratory testing you must tell your doctor or the laboratory personnel that you are taking or have recently taken Ketovite Tablets, because biotin may affect results of such Izlasiet visu dokumentu
Health Products Regulatory Authority 20 August 2020 CRN009W45 Page 1 of 4 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Ketovite Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains; Thiamine hydrochloride 1.0 mg Riboflavin 1.0 mg Pyridoxine hydrochloride 0.33 mg Nicotinamide 3.3 mg Calcium pantothenate 1.16 mg Ascorbic acid 16.6 mg all-rac-Alpha-Tocopheryl acetate 5.0 mg Inositol 50.0 mg Biotin 0.17 mg Folic acid 0.25 mg Acetomenaphthone 0.50 mg For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Tablets. Yellow tablets. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Vitamin supplement for the prevention of vitamin deficiency in conditions such as galactosaemia, disaccharide intolerance, phenylketonuria and other disorders of carbohydrate or amino acid metabolism, as well as in patients who are on restricted, specialised or synthetic diets. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology For adults, children over 4 years, and the elderly: One tablet three times daily, by oral administration. 4.3 CONTRAINDICATIONS Hypersensitivity to the active substances or to any of the excipients listed in section 6.1. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE The recommended dose should not be exceeded without medical advice. Interference with clinical laboratory tests Biotin may interfere with laboratory tests that are based on a biotin/streptavidin interaction, leading to either falsely decreased or falsely increased test results, depending on the assay. The risk of interference is higher in children and patients with renal impairment and increases with higher doses. When interpreting results of laboratory tests, possible biotin interference has to Health Products Regulatory Authority 20 August 2020 CRN009W45 Page 2 of 4 be taken into consideration, especially if a lack of coherence with the clinical presentation is observed (e.g. thyroid test results mimicking Graves' disease in asymptomatic patients taking biotin or false negative troponin test results Izlasiet visu dokumentu